Julie Gralow: Mobile App Symptom Monitoring Helps Maintain Quality of Life in Advanced Cancer

oncodaily - Julie Gralow, Chief Medical Officer of the American Society of Clinical Oncology, shared a post on X: “Use Of Mobile App For Proactive Symptom Monitoring Helped Patients With Advanced Cancer […]

AI Summary: A smartphone-based symptom monitoring program preserved quality of life for people with advanced cancer by enabling real‑time reporting and prompt clinician response. The intervention maintained patient function and well‑being compared with usual care, demonstrating a scalable, low‑cost way to keep symptoms under control — because yes, your phone can sometimes do what clinic schedules cannot.

#healthcare #digitalhealth #oncology #cancerresearch #clinicaltrials #telemedicine #healthit

21 days / oncodaily

4 wks / oncodaily


Back to Top / Sun, June 7, 2026, 6:22 am / permalink 24930 / 3 stories in 4 wks /




Related Stories


Deep‑learning pathomics platform may predict immunotherapy response in lung cancer / 2 months

Small study reports 100% one‑year survival after lung transplant / 20 hrs

High‑dose targeted radiation shows promise for huge bile duct tumors / 3 months

AI model generalizes to predict immunotherapy response across cancers / 6 days

AI face photos may predict cancer survival years earlier / 2 months

One Medical reports cybersecurity incident affecting seniors' unit / 21 days

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 7 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Medicare Advantage (not listed), Pfizer, Pancreatic Cancer, Infant Health and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.